Pediatric Brain Tumor Market Analysis | Size, Share, Demand and Growth | Forecast - 2023 - PowerPoint PPT Presentation

About This Presentation

Pediatric Brain Tumor Market Analysis | Size, Share, Demand and Growth | Forecast - 2023


Pediatric Brain Tumor Market Research Report, Forecast Period 2017-2023. The Global Market is based on Industry Size, Share, Trend and Growth. Also, the industry insight includes regional and segmental shares, the report is published by MRFR. – PowerPoint PPT presentation

Number of Views:72


Transcript and Presenter's Notes

Title: Pediatric Brain Tumor Market Analysis | Size, Share, Demand and Growth | Forecast - 2023

Pediatric Brain Tumor Market
Industry Analysis, Size, Share, Growth, Trends,
and Forecast to 2023
Pediatric Brain Tumor Market
Pediatric Brain Tumor Market Overview
Pediatric brain tumor can be defined as an
unnatural growth of a normal cell inside the
brain of a children. These tumors are of two
types cancerous (malignant) and noncancerous
(benign). The type is quite common in children.
Governments are putting in great effort to
counter this type of disease, which is giving
substantial traction to the global pediatric
brain tumor market. The market can achieve a
growth by 4.1 CAGR during the forecast period to
surpass USD 1659.4 million worth mark during the
forecast period of 2018 to 2023. Factors like
heightened medical facilities, inclusion of
top-class medical equipment, better government
initiative, high investment from both private and
government sectors, concerns shown by research
development sector, better insurance coverage,
and others can inspire the global pediatric brain
tumor market growth in the coming years. Get
Free Sample of Report _at_  https//www.marketresearc
Pediatric Brain Tumor Market
Pediatric Brain Tumor Market Segmentation A
better understanding of the global pediatric
brain tumor market can be segmented on the basis
of types, diagnosis, and treatment. By type, the
global pediatric brain tumor market can be
segmented into mixed neuronal-glial tumors,
gliomas, choroid plexus papilloma/carcinoma,
embryonal tumors, meningeal tumors, tumors
arising from non-neuroepithelial tissue, and
others. The gliomas segment includes malignant
gliomas, astrocytoma, and others. Mixed
neuronal-glial tumors are segmented into
pleomorphic xanthoastrocytoma, subependymal giant
cell tumor, ganglioglioma, and others. Embryonal
tumors segment encompasses primitive
neuroectodermal tumor (PNET), atypical
teratoid/rhabdoid tumor, and others. Tumors
arising from non-neuroepithelial tissue includes
pineal region tumors, craniopharyngioma, and
others. Based on the diagnosis, the global
pediatric brain tumor market can be segmented
into physical exam, Imaging tests, lumbar
puncture (spinal tap), brain or spinal cord tumor
biopsy, blood urine tests, and others. Imaging
tests includes Computed Tomography (CT) scan,
Magnetic Resonance Imaging (MRI) scan, Angiogram,
Positron Emission Tomography (PET) scan, and
others. Magnetic Resonance Imaging (MRI) scan
comprises Magnetic Resonance Spectroscopy (MRS),
Magnetic Resonance Angiography (MRA), Functional
MRI (fMRI), Magnetic Resonance Perfusion, and
others. Brain or spinal cord tumor biopsy can be
studied better on the basis of craniotomy,
stereotactic needle biopsy, and other. By
treatment, the pediatric brain tumor market has
been studied on the basis of therapies, surgery,
drug treatment, and others. Surgery segment
includes resection (removal), shunt
placement/revision, surgical biopsy, and others.
Therapies segment has been studied with focus on
chemotherapy, radiation therapy, targeted
therapy, and others. Chemotherapy segment covers
carboplatin, cisplatin, carmustine (BCNU),
vincristine, etoposide, cyclophosphamide,
methotrexate, lomustine (CCNU), thiotepa,
temozolomide, and others. Drug treatment segment
includes hormones, corticosteroids, anti-seizure
drugs (anti-epileptics), and others.  By end
user, the pediatric brain tumor market consists
hospitals clinics, medical research centers,
academic institutes, and others.
Pediatric Brain Tumor Market
Pediatric Brain Tumor Market Regional Analysis
By considering the pediatric brain tumor market
on a region-specific level, MRFR included regions
like North America, Europe, Asia Pacific (APAC),
and the Rest-of-the-World (RoW). These segments
are expected to thrive on various demographic
features that can be studied to increase the
profit margin in the coming years. North America
has the better market coverage and it can grow in
the coming years with strong contributions made
by the US and Canada. This is due to high level
of awareness better market percolation of various
industries, hike in healthcare expenditure, and
various other factors. Europe is also in the line
to earn revenues. The regional healthcare sector
has similar market benefits like that of North
America. In the APAC region, the market can
depend on revamping healthcare sector, which can
fetch in better revenues for the market.
Browse Report _at_ https//www.marketresearchfuture.
Pediatric Brain Tumor Market
Pediatric Brain Tumor Market Competitive Analysis
The global pediatric brain tumor market is all
set to gain from the participation of several
top-notch players. These companies are expected
to launch their own strategic moves to ensure
easy stay in the global market. Their tactical
moves are expected to include merger, innovation,
collaboration, branding, and others. MRFR
enlisted these companies for a better
understanding of the market in the coming days.
These companies are AbbVie Inc. (US), Abbott.
(US), Agios, Inc. (US), Akorn, Inc. (US), Bayer
AG (US), Baxter (US), Novartis AG (Switzerland),
Epizyme, Inc. (US), Mylan N.V. (US), and others.
In August 2019, Moleculin Biotech announced
their move forward with the new WP1066 that has
recently got a clean chit from FDAs. The
medicine, as per the market analysts would help
the global presence of the Moleculin Biotech in
stepping forward.
Ask Questions To The Experts _at_
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit or contact us at Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
(No Transcript)
Write a Comment
User Comments (0)